What is Flector EP Tissugel and when is it used?

Flector EP Tissugel is a self-adhesive, flexible patch to be placed on the skin, containing the active ingredient diclofenac, a substance with analgesic and anti-inflammatory properties.

Flector EP Tissugel is indicated for the local and symptomatic treatment of osteoarthritis of the knee (gonarthrosis).

Flector EP Tissugel is used for the local treatment of pain, inflammation and swelling as a result of sprains, dislocations, bruises and strains.

When not to use Flector EP Tissugel?

Do not use Flector EP Tissugel:

If you are hypersensitive to the active substance or to an excipient according to the composition (see «What does Flector EP Tissugel contain?»),

If you are hypersensitive to other painkillers and anti-inflammatory drugs (e.g. acetylsalicylic acid).

Flector EP Tissugel must not be used on open wounds (e.g. skin abrasions, cuts, etc.) or on eczematous skin.

When is caution required when using Flector EP Tissugel?

Flector EP Tissugel must not come into contact with the eyes and mucous membranes.

Tell your doctor, pharmacist or druggist if you:

have already used similar products (rheumatism ointments) and these have led to allergic reactions,

Suffer from other illnesses, have allergies or take other medicines (including those you bought yourself!) or use them externally.

Can Flector EP Tissugel be used while pregnant or breastfeeding?

As a precautionary measure, you should not use Flector EP Tissugel while pregnant or breastfeeding, unless expressly stated medical prescription.

How do you use Flector EP Tissugel?

Twice a day, morning and evening, 1 self-adhesive plaster is applied to the skin area to be treated.

Before use, remove the clear film that protects the gelatinous surface.

Instructions for use: see image on the bag.

If the patch does not adhere well, as may be the case on the elbow, knee or ankle, use the elastic mesh stocking included in the pack for additional fixation.

The duration of treatment should not exceed 14 days.

The use of Flector EP Tissugel in children has not been systematically evaluated.

Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Flector EP Tissugel have?

Flector EP Tissugel is generally well tolerated. The following side effects may occur when using Flector EP Tissugel:

Itching, redness, swelling or blistering at the treated area.

Very rarely, severe skin rashes, allergic reactions such as wheezing, shortness of breath or facial swelling, or increased sensitivity to sunlight have been observed.

If any of the following side effects occur, stop using Flector EP Tissugel and tell your doctor immediately: severe skin rash, wheezing, shortness of breath or swelling of the face.

If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist.

What else needs to be considered?

The medicine should be stored at room temperature (15-25 °C) and out of the reach of children.

The medicinal product may only be used up to the date marked «EXP» on the container.

Once the envelope is first opened, the patches should be used within 3 months. After cutting, the packaging can be resealed at any time so that the patches retain their moisture.

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Flector EP Tissugel contain?

Active ingredients: Diclofenac Epolamine, 182 mg per patch (corresponding to a concentration of 1.3% diclofenac epolamine, or 1% diclofenac sodium salt).

Excipients: propylene glycol, preservative: propyl parahydroxybenzoate (E216), methyl parahydroxybenzoate (E218), flavorings.

Approval number

52022 (Swissmedic).

Where can you get Flector EP Tissugel? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Packs of 2, 5, 10 and 15 patches.

Packs of elastic fishnet stockings.

Authorization holder

IBSA Institut Biochimique SA, Lugano.

This leaflet was last checked by the Medicines Agency (Swissmedic) in November 2016.